We are pleased to announce Partner Elliott Phillips has been selected this year for the Global Elite Directory 2021.
Jan 29, 2021
Arbitral Tribunals Beware: Better Keep an Eye on Potential Corruption Involving Consent Awards – Flore Poloni & Nicolas Brooke
Partners Flore Poloni and Nicolas Brooke examine in the Kluwer Arbitration Blog the recent Paris Court of Appeal ruling in relation to the dispute involving the State of Libya and French company, SORELEC.
Jan 29, 2021
Partner Hermès Marangos examines in The Times the recent UK Supreme Court ruling on business interruption insurance and its impacts in relation to businesses and the wider insurance industry as a result of the COVID-19 pandemic.
Jan 28, 2021
Taking the law into their own hands: how investors are using litigation to achieve ESG impact – Sylvie Gallage-Alwis
Partner Sylvie Gallage-Alwis comments in Responsible Investor in relation to how litigation can be used as an ESG tool to achieve social and environmental impact in 2021.
Jan 27, 2021
UK’s financial regulator rapped following LCF collapse – Paul Brehony, Abdulali Jiwaji and Johnny Shearman
Paul Brehony, Abdulali Jiwaji and Johnny Shearman examine the report into the FCA / London Capital & Finance (LC&F) and its failures to effectively regulate and supervise LC&F and what this means for the FCA.
Jan 25, 2021
Johnny Shearman, Head of Knowledge and Legal Services, comments in relation to the recent Zuberi v Lexlaw judgment regarding Damages Based Agreements, in Law360.
Jan 22, 2021
Class actions and insurance: another shock of the year 2020 or an unfinished reform? – Emmanuèle Lutfalla and Simon Fitzpatrick
Partner Emmanuèle Lutfalla and Legal Assistant Simon Fitzpatrick discuss the arrival of the new European directive on collective actions, as well as its implications for insurers, in La Gazette du Palais.
Jan 20, 2021
Partner Sylvie Gallage-Alwis and principal Marta Villarraga at Exponent Inc discuss how the EU Medical Device Regulation 2017/745 of the European Parliament and of the Council of April 5, 2017, will soon become fully applicable, providing for a new legal framework for manufacturers, distributors and notified bodies of medical devices. They will further provide practical tips for manufacturers to consider as the countdown is almost over, in Law360.
Jan 19, 2021
Arbitration courts: beware of the trap of an absence of corruption allegations – Flore Poloni and Nicolas Brooke
Partners Flore Poloni and Nicolas Brooke discuss the setting aside of an arbitral award by The Paris Court of Appeal calling on the Libyan state to pay 452 million euros to the French company Sorelec, ruling that the underlying contract had been obtained due to corruption. They examine concerns over evidentiary standards relating to corruption allegations and analyse how far the arbitration court should have gone to uncover the alleged history of the contract, in Le Monde du Droit.
Jan 15, 2021
Associate Olivia Flasch discuss the issuing of the International Court of Justice’s final judgment in the case of Immunities and Criminal Proceedings (Equatorial Guinea v. France) and how the judgment against Equatorial Guinea bolsters anti-corruption efforts but may complicate the future of diplomatic relations.
Jan 14, 2021
Johnny Shearman, Head of Knowledge and Legal Services, examines his top 3 decisions from 2020 that dealt with the Disclosure Pilot Scheme and looks to 2021 as a pivotal year for the the Pilot.
Jan 12, 2021
Proof of its agility, the ICC International Court of Arbitration introduces new rules – Flore Poloni
Partner Flore Poloni discusses how the International Chamber of Commerce (ICC) recently amended its regulations to strive for ever greater efficiency and flexibility for its users, while taking into account the Covid-19 pandemic, in La Gazette du Palais.
Jan 08, 2021